- Release Date: 14/06/22 09:04
- Summary: ACW announces Phase 2 trial designs for AD & MDD
- Price Sensitive: Yes
- Download Document 556.64KB
- Forums
- ASX - By Stock
- Ann: ACW announces Phase 2 trial designs for AD & MDD
ACW
actinogen medical limited
Add to My Watchlist
11.1%
!
3.0¢

Ann: ACW announces Phase 2 trial designs for AD & MDD
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.0¢ |
Change
0.003(11.1%) |
Mkt cap ! $92.08M |
Open | High | Low | Value | Volume |
3.0¢ | 3.0¢ | 2.9¢ | $267.8K | 9.041M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 1186131 | 2.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 2232035 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1186131 | 0.028 |
8 | 726221 | 0.027 |
7 | 979123 | 0.026 |
14 | 2446589 | 0.025 |
7 | 1984166 | 0.024 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 2232035 | 6 |
0.031 | 1941199 | 7 |
0.032 | 1207666 | 9 |
0.033 | 1131127 | 9 |
0.034 | 781988 | 6 |
Last trade - 13.36pm 15/09/2025 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman and CEO
Hank Holland
Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online